EN 
ES 
NephCure, a leading nonprofit organization advocating to ensure that all individuals with rare, protein-spilling kidney disease have equitable access to the care and treatments that offer them the best kidney health outcome possible, is proud to celebrate the inaugural Membranous Nephropathy Awareness Day on August 11, 2026.
This day is dedicated to raising awareness of membranous nephropathy (MN), a kidney disease that causes injury to the small filters (glomeruli) in kidney tissue. It occurs when the person makes antibodies that damage kidney cells which form part of the kidney filters. Doctors most often diagnose MN in adults, it is a rare disease in children. Most cases of MN only affect the kidneys.
Today, there are more than 10 clinical trials studying new, potential treatments for MN, representing significant momentum in the field. Although MN is one of the more common forms of rare kidney disease in adults, many patients continue to experience delayed diagnosis, limited disease awareness, and barriers to accessing specialized care.
In honor of Membranous Nephropathy Awareness Day, NephCure is highlighting educational programs and resources designed to empower patients, caregivers, and healthcare professionals with accessible, up-to-date information about MN, treatment options, and disease management.
Join NephCure on August 11, for a free virtual MN Patient Meet & Greet at 7:00pm ET.
This community event will provide patients, caregivers, and families affected by MN with an opportunity to connect, share experiences, ask questions, and build meaningful relationships with others navigating membranous nephropathy. Whether newly diagnosed or living with MN for years, all members of the community are welcome to attend.
Click here to register for the free, virtual MN Patient Meet & Greet.
Other Ways to Get Involved for Membranous Nephropathy Awareness Day
NephCure invites everyone to help raise awareness by downloading and sharing the Membranous Nephropathy Awareness Day social media toolkit. By sharing awareness graphics, educational resources, and personal stories, supporters can help educate others about MN and expand the reach of the rare kidney disease community.
In order to capture the MN patient experience, NephCure is encouraging its community to complete this patient survey. Results from this survey will help shape future programs, resources, events, and advocacy efforts at NephCure.
Patients living with MN are also encouraged to share their personal stories on social media. Every story helps increase awareness, encourage earlier diagnosis, and remind others living with MN that they are not alone.
Why Awareness Matters
Despite exciting advances in research, many people living with MN still face significant challenges before receiving an accurate diagnosis or finding specialized care, and there are currently no FDA approved treatments for MN. NephCure is sharing resources this Membranous Nephropathy Awareness Day that equip patients to support research and shape the future of care.
About NephCure
NephCure’s mission is to ensure that all individuals with rare, protein-spilling kidney disease have equitable access to the care and treatments that offer them the best kidney health outcome possible. Founded in 2000 by a group of committed patient parents, NephCure has invested more than $40 million in kidney disease research and helped create a landscape where there are now new treatments and more than 60 interventional drug trials for rare kidney diseases. NephCure is a U.S. tax-exempt 501(c)(3) public charity.
